Agribusiness giant Monsanto Co. is challenging a growing trend among dairies to label their milk “hormone free,” saying those claims mislead consumers into believing that the cow growth ...

Monsanto Co. is unloading a harvest of controversy with its $300 million sale of the Posilac cow hormone to drugmaker Eli Lilly & Co.Posilac has never been a big part of St. Louis-based Monsanto ...

Agriculture biotech giant Monsanto Co. said it is planning to sell its business that produces a controversial hormone used to boost milk production in dairy cows. The company said it plans to sell ...

A group of Ontario farmers is claiming victory after Monsanto Co. agreed to sell its Posilac brand of synthetic cow hormones to drug maker Eli Lilly and Co. for $300 million.

Two weeks after Monsanto said it was selling off the business that makes artificial growth hormone for dairy cows, it's found a buyer: Eli Lilly and Co., which has agreed to pay $300 million.

Monsanto’s argument: The genetically engineered rBGH, which increases a dairy cow’s milk output by about a gallon a day, has already passed muster with the U.S. Food and Drug Administration.

Monsanto has assured the public over and over that its flagship Roundup herbicide doesn’t cause ... but its old-line herbicide business remains quite the cash cow, as its 2014 annual report shows.

Monsanto Co. has agreed to pay the University of California $100 million to settle a patent dispute over a growth hormone used to increase milk production in cows. The agreement, which includes ...